98
Participants
Start Date
December 31, 2005
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Pregabalin
"Pregabalin treatment, given as 2 divided doses, is initiated at a dose of 150 mg/day (75 mg BID).~Based on individual subject response and tolerability, the dosage may be increased to 300 mg/day after 1 week (150 mg BID given as two 75-mg capsules BID). Based on subjects individual response and tolerability, dosage can be incrementally increased further after an additional week to 600 mg/day (300 mg BID given as four 75-mg capsules BID)."
Pfizer Investigational Site, Athens
Pfizer Investigational Site, Athens
Pfizer Investigational Site, Mesogion, Athen
Pfizer Investigational Site, Pátrai
Pfizer Investigational Site, Thessaloniki
Pfizer Investigational Site, Thessaloniki
Pfizer Investigational Site, Heraklio
Pfizer Investigational Site, Thessaloniki
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY